Home News About us Comitato scientifico Iscriviti Utenti Etica Contenuti Guida Faq Stage Contatti ☰
Logo Pharmamedix
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Zopiclone

Imovane, Zopiclone

Bibliografia - Quali fonti bibliografiche per Zopiclone?

  1. Alderman C.P. et al., Ann. Pharmacother., 2001, 35(11), 1378.

  2. Allain H. et al., Sleep., 1991, 14(5), 408.

  3. Aranko K. et al., Br. J. Clin. Pharmacol., 1994, 38, 363.

  4. Ashton H., Psychiatr. An., 1995, 25, 158.

  5. Becquemont L. et al., Drug Metab. Dispos., 1999, 27(9), 1068.

  6. Begg E.J. et al., NZ Med. J., 1992, 105(944), 428.

  7. Blanchard J.C. et al., Pharmacology, 1983, 17 Suppl. 2, 59.

  8. Blaschke G. et al., Chirality, 1993, 5, 419.

  9. Caille G. et al., Biopharm. Drug Dispos., 1984, 5, 117.

  10. Dehlin O. et al., Curr. Med. Res. Opin., 1995, 13(6), 317.

  11. Diav-Citrin O. et al., Am. J. Perinatol., 1999, 16(4), 157.

  12. Dresser G.K. et al., Clin. Pharmacokinet., 2000, 38(1), 41.

  13. Dorian P. et al., Pharmacology, 1983, 27 (Suppl 2), 228.

  14. Drewes A.M. et al., Scand. J. Rheumatol., 1998, 27(3), 180.

  15. Fava M. et al., Biol. Psychiatry, 2006, 59(11), 1052.

  16. Fernandez C. et al., Drug Metab. Dispos., 1993, 21, 1125.

  17. Fleming J.A. et al., Int. Clin. Psychopharmacol., 1990, 5 Suppl 2, 29.

  18. Fontaine R. et al., Int. Clin. Psychopharmacol., 1990, 5(3), 173.

  19. Fung H.T. et al., Clin. Toxicol. (Phila), 2008, 46(2), 167.

  20. Fung H.T. et al., Clin. Toxicol. (Phila), 2009, 47(9), 902.

  21. Gaillot J. et al., Pharmacology, 1983, 27 Suppl. 2, 76.

  22. Gaillot J. et al., Sleep, 1987, 10 Suppl. 1, 7.

  23. Goa K.L., Heel R.C., Drugs, 1986, 32, 48.

  24. Gronblad M. et al., Clin. Rheumatol., 1993, 12(2), 186.

  25. Hajak G. et al., Int. Clin. Psychopharmacol., 1994, 9(4), 251.

  26. Hempel G., Blaschke G., J. Chromatogr. Biomed. Appl., 1996, 675, 139.

  27. Houghton G.W. et al., Int. J. Clin. Pharmacol. Ther. Toxicol., 1985, 23, 97.

  28. Jalava K.M. et al., Eur. J. Clin. Pharmacol., 1996, 51(3-4), 331.

  29. Katsunuma H. et al., Psychiatry Clin. Neurosci., 1998, 52(2), 198.

  30. Matheson I. et al., Br. J. Clin. Pharmacol., 1990, 30, 267.

  31. Noble S. et al., Drugs, 1998, 55(2), 277.

  32. Pick C.G. et al., Pharmacol. Biochem. Behav., 2005, 81(3), 417.

  33. Pollack M. et al., Arch. Gen. Psychiatry, 2008, 65(5), 551.

  34. Terzano M.G. et al., Drug Saf., 2003, 26(4), 261.

  35. Tornio A. et al., Eur. J. Clin. Pharmacol., 2006, 62(8), 645.

  36. Tsutsui S. et al., J. Int. Med. Res., 2001, 29(3), 163.

  37. Villikka K. et al., Clin. Pharmacol. Ther., 1997, 62(6), 629.

  38. Viron B. et al., Int. Clin. Psychopharmacol. 1990, 5 Suppl. 2, 95.